Lactic acid bacteria colonization and clinical outcome after probiotic supplementation in conventionally treated bacterial vaginosis and vulvovaginal candidiasis

Microbes and Infection

Volumn 12, Issue 10, 2010, Pages 691-699

  Ehrström, Sophia ^a   Daroczy, Katalin ^b   Rylander, Eva ^a   Samuelsson, Carolina ^c   Johannesson, Ulrika ^a   Anzén, Bo ^a   Påhlson, Carl ^b  

^a DANDERYD HOSPITAL   (Sweden)

^b MÄLARDALEN UNIVERSITY   (Sweden)

^c HALMSTAD HOSPITAL   (Sweden)

Author keywords

Bacterial vaginosis; Lactobacilli; Probiotics; RAPD analysis; Vulvovaginal candidiasis

Indexed keywords

BACTERIAL DNA; CLINDAMYCIN; CLOTRIMAZOLE; DNA 16S; GENOMIC DNA; PLACEBO; PROBIOTIC AGENT;

ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CANDIDA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; FUNGUS CULTURE; HUMAN; LACTOBACILLUS FERMENTUM; LACTOBACILLUS GASSERI; LACTOBACILLUS RHAMNOSUS; MAJOR CLINICAL STUDY; NONHUMAN; OUTCOME ASSESSMENT; PEDIOCOCCUS ACIDILACTICI; PRIORITY JOURNAL; RANDOM AMPLIFIED POLYMORPHIC DNA; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; TREATMENT DURATION; VAGINA BLEEDING; VAGINA CANDIDIASIS; VAGINA DISCHARGE; VAGINA SMEAR; VAGINAL PRURITUS; VAGINITIS; VULVA PRURITUS;

ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS; CANDIDIASIS, VULVOVAGINAL; DNA FINGERPRINTING; DNA, BACTERIAL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LACTOBACILLUS; MIDDLE AGED; PEDIOCOCCUS; PROBIOTICS; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; RECURRENCE; TREATMENT OUTCOME; VAGINA; VAGINOSIS, BACTERIAL; VULVA; YOUNG ADULT;

BACTERIA (MICROORGANISMS); LACTOBACILLUS FERMENTUM;

EID: 77956264287     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2010.04.010     Document Type: Article

References (49)

1. Anukam K.C., Osazuwa E.O., Ahonkhai I., Gregor R. Lactobacillus vaginal microbiota of women attending a reproductive health care service in Benin City, Nigeria. Sex. Transm. Dis. 2006, 33:59-62.
2. Hyman R.W., Fukushima M., Diamond L., Kumm J., Giudice L.C., Davis R.W. Microbes on the human vaginal epithelium. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:7952-7957.
3. Masfaril A.N., Duerden B.I., Kinghorn G.R. Quantitative studies of vaginal bacteria. Genitourin. Med. 1986, 62:256-263.
4. Boskey E.R., Telsch K.M., Whaley K.J., Moench T.R., Cone R.A. Acid production by vaginal flora in vitro is consistent with the rate and extent of vaginal acidification. Infect. Immun. 1999, 67:5170-5175.
5. Boskey E.R., Cone R.A., Whaley K.J., Moench T.R. Origins of vaginal acidity: high D/L lactate ratio is consistent with bacteria being the primary source. Hum. Reprod. 2001, 16:1809-1813.
6. Boris S., Suarez J.E., Vasquez F., Barbes C. Adherence of human vaginal lactobacilli to vaginal epithelial cells and interaction with uropathogens. Infect. Immun. 1998, 66:1985-1989.
7. Eschenbach D.A., Davick P.R., Williams B.L., Klebanoff S.J., Young-Smith K., Critchhlow C.M., Holmes K.K. Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J. Clin. Microbiol. 1989, 27:251-256.
8. Kaewsrichan J.K., Peeyananjarassri, Kongprasertkit J. Selection and identification of anaerobic lactobacilli producing inhibitory compounds against vaginal pathogens. FEMS Immunol. Med. Microbiol. 2006, 48:75-83.
9. Harold M.L., Richardson B.A., Nyange P.M., Lavreys L., Hillier S.L., Chohan B., Mandaliya K., Ndinya-Achola J.O., Bwayo J., Kreiss J. Vaginal lactobacilli, microbial flora, and risk of human Immunodeficiency Virus type 1 and sexually transmitted disease Acquisition. Infect. Dis. 1999, 180:1863-1868.
10. Okkers D.J., Dicks L.M.T., Silvester M., Joubert J.J., Odendaal H.J. Characterization of pentocin TV35b, a bacteriocin-like peptide isolated from Lactobacillus pentosus with a fungistatic effect on Candida albicans. J. Appl. Microbiol. 1999, 87:726-734.
11. Eshenbach D.A. History and review of bacterial vaginosis. Am. J. Obstet. Gynecol. 1993, 169:441-445.
12. Vásquez A., Jakobsson T., Ahrné S., Forsum U., Molin G. Vaginal Lactobacillus flora of healthy Swedish women. J. Clin. Microbiol. 2002, 40:2746-2749.
13. Amsel R., Totten P.A., Spiegel C.A., Chen K.C., Eschenbach D., Holmes K.K. Non-specific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am. J. Med. 1983, 74:14-22.
14. Kane K.Y., Pierce R. What are the most effective treatments for bacterial vaginosis in non-pregnant women?. J. Fam. Pract. 2001, 5:399-400.
15. Joesoef M.R., Schmid G. Bacterial vaginosis. Clin. Evid. 2004, 11:2054-2063.
16. Bradshaw C.S., Morton A.N., Hocking J., Garland S.M., Morris M.B., Moss L.M., Horvath L.B., Kuzevska I., Fairley C.K. High recurrence rates of bacterial vaginosis over the course of 12 Months after oral metronidazole therapy and factors associated with recurrence. J. Infect. Dis. 2006, 193:1478-1486.
17. Sobel J.D., Schmitt C., Meriwether C. Long-term follow-up of patients with bacterial vaginosis treated with oral metronidazole and topical clindamycin. J. Infect. Dis. 1993, 167:783-784.
18. Beigi R.H., Austin M.N., Meyn L.A., Krohn M.A., Hillier S.L. Antimicrobial resistance associated with the treatment of bacterial vaginosis. Am. J. Obstet. Gynecol. 2004, 191:1124-1129.
19. Nyirjesy P., McIntosh M.J., Gattermeir D.J., Scumacher R., Steinmetz J.I., Joffrion J.L. The effects of intravaginal clindamycin and metronidazole therapy on vaginal lactobacilli in patients with bacterial vaginosis, Am. J. Obstet. Gynecol. 2006, 194:1277-1282.
20. Hillier S.L., Nugent R.P., Escenbach D.A., Krohn M.A., Gibbs R.S., Martin D.H., Cotch M.F., Edelman R., Pastorek J.G., Rao A.V., McNellis D., Regan J.A., Carey J.C., Klebanoff M.A. Association between bacterial vaginosis and preterm delivery of a low-birthweight infant, the vaginal infections and prematurity study group. N. Engl. J. Med. 1995, 333:1737-1742.
21. Larsson P.G., Bergström M., Forsum U., Jacobsson B., Strand A., Wolner-Hanssen P. Bacterial vaginosis. Transmission, role in genital tract infection and pregnancy outcome: an enigma. APMIS 2005, 113:233-245.
22. Ness R.B., Kip K.E., Hillier S.L., Soper D.E., Stamm C.A., Sweet R.L., Rice P., Richter H.E. A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease. Am Epidemiol. 2005, 162:585-589.
23. de Leon E.M., Jacober S.J., Sobel J.D., Foxman B. Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes. BMC Infect. Dis. 2002, 2:1.
24. Fidel P.L., Sobel J.D. Immunopathogenesis of recurrent vulvovaginal candidiasis. Clin. Microbiol. Rev. 1996, 9:335-348.
25. Fidel P.L., Vazquez J., Sobel J.D. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin. Microbiol. Rev. 1999, 12:80-96.
26. Sobel J.D., Chaim W. Vaginal microbiology of women with acute recurrent vulvovaginal candidiasis. J. Clin. Microbiol. 1996, 34:2497-2499.
27. Sobel J.D. Vulvovaginal candidosis. Lancet 2007, 9577:1961-1971.
28. Sobel J.D. Vaginitis. N. Engl. J. Med. 1997, 337:1896-1903.
29. Kent H.L. Epidemiology of vaginitis. Am. J. Obstet. Gynecol. 1991, 165:1168-1176.
30. Osset J., Bartolome R.M., Garcia E., Andreu A. Assessment of the capacity of Lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells. J. Infect. Dis. 2001, 183:485-491.
31. Osset J., Garcia E., Bartolome R.M., Andreau A. Role of Lactobacillus as protector against vaginal candidiasis. Med. Clin. 2001, 117:285-288.
32. Rönnqvist D., Forsgren-Brusk U., Husmark U., Grahn-Håkansson E. J. Med. Microbiol. 2007, 56:1500-1504.
33. Antonio M.A.D., Hillier S.L. DNA fingerprinting of Lactobacillus crispatus strain CTV-05 by repetitive element sequence-based PCR analysis in a pilot study of vaginal colonization. J. Clin. Microbiol. 2003, 41:1881-1887.
34. Gardiner G., Heinemann C., Bruce A.W., Beuerman D., Reid G. Persistence of Lactobacillus fermentum RC-14 and Lactobacillus rhamnosus GR-1 but not L. rhamnosus GG in the human vagina as demonstrated by randomly amplified polymorphic DNA. Clin. Diagn. Lab. Immunol 2002, 9:92-96.
35. Reid G., Bruce A.W., Fraser N., Heinemann C., Owen J., Henning B. Oral probiotics can resolve urogenital infections. FEMS Immunol. Med. Microbiol. 2001, 30:49-52.
36. Rönnqvist P.D., Forsgren-Brusk U.B., Grahn-Håkansson E.E. Lactobacilli in the female genital tract in relation to other genital microbes and vaginal pH. Acta. Obstet. Gynecol. Scand. 2006, 85:726-735.
37. Petricevic L., Witt A. The role of Lactobacilli casei rhamnosus Lcr35 in restoring the normal vaginal flora after antibiotic treatment of bacterial vaginosis. BJOG 2008, 115:1369-1374.
38. Reid G., Charbonneau D., Erb J., Kochanowski B., Beuerman D., Poehner R., Bruce A.W. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol. Med. Microbiol. 2003, 35:131-134.
39. Eriksson K., Carlsson B., Forsum U., Larsson P.G. A double-blind treatment study of bacterial vaginosis with normal vaginal lactobacilli after an open treatment with vaginal clindamycin ovules. Acta Derm. Venereol. 2005, 85:42-46.
40. Hilton E., Rindos P., Isenberg H. Lactobacillus GG vaginal suppositories and vaginitis. J. Clin. Microbiol. 1995, 33:1433.
41. Falagas M.E., Betsi G.I., Athanasiou S. Probiotics for prevention of recurrent vulvovaginal candidiasis: a review. J. Antimicrob. Chemother. 2006, 58:266-272.
42. Food and Agriculture Organization of the United Nations and World Health Organization, 2001 posting date. Regulatory and clinical aspects of dairy probiotics, Food and Agriculture Organization of the United Nations and World health Organization Expert Consultation report. Food and Agriculture Organization of the United Nations and World health Organization Working group report (online).
43. Antonio M.A.D., Hawes S.E., Hillier S.L. The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species. J. Infect. Dis. 1999, 180:1950-1956.
44. Pavlova S.I., Kilic A.O., Kilic S.S., So J.-S., Nader-Macias M.E., Simoes J.A., Tao L. Genetic diversity of vaginal lactobacilli from women in different countries based on 16S rRNA gene sequences. J. Appl. Microbiol. 2002, 92:451-459.
45. Stoyancheva G.D., Danova S.T., Boudakov I.Y. Molecular identification of vaginal lactobacilli isolated from Bulgarian women. Antonie Van Leeuwenhoek 2006, 90:201-210.
46. Zhong W., Millsap K., Bialkowska-Hobrzanska H., Reid G. Differentiation of Lactobacillus species by molecular typing. Appl. Environ. Microbiol. 1998, 64:2418-2423.
47. Strus M., Kucharska A., Kukla G., Brzychczy-Włoch M., Maresz K., Heczko P.B. The in vitro activity of vaginal Lactobacillus with probiotic properties against Candida. Infect. Dis. Obstet. Gynecol. 2005, 13:69-75.
48. Anukam K., Osazuwaa E., Ahonkhaia I., Ngwue M., Osemene G., Bruceb A.W., Reid G. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. Microbes Infect. 2006, 6:1450-1454.
49. Larsson P.G., Stray-Pedersen B., Ryttig K.R., Larsen S. Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study. BMC Woman's Health 2008, 8:3.